SCM
VIR icon

Sio Capital Management’s Vir Biotechnology VIR Stock Holding History

Sio Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
1,075,274
-423,346
-28% -$4.03M 1.81% 24
2026
Q1 		$13.4M Buy
1,498,620
+1,020,277
+213% +$8.13M 1.93% 16
2025
Q4 		$2.88M Hold
478,343
– – 0.45% 43
2025
Q3 		$2.73M Hold
478,343
– – 0.69% 33
2025
Q2 		$2.41M Buy
478,343
+4,736
+1% +$25.4K 0.92% 29
2025
Q1 		$3.07M Sell
473,607
-581,044
-55% -$5.17M 0.91% 26
2024
Q4 		$7.74M Buy
+1,054,651
New +$8.32M 2.18% 16

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sio Capital Management's VIR Position: Q2 2026 in Review

Sio Capital Management reduced its Vir Biotechnology (VIR) stake by 28% in Q2 2026, selling an estimated $4.03M and leaving 1,075,274 shares worth $11M. The position accounts for 1.81% of the portfolio, ranked #24.

Sio Capital Management first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.4M in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Sio Capital Management held 1,075,274 shares of Vir Biotechnology worth $11M as of Q2 2026.
  • Sio Capital Management sold 423,346 Vir Biotechnology shares in Q2 2026, an estimated $4.03M.
  • Vir Biotechnology made up 1.81% of Sio Capital Management's portfolio in Q2 2026, its #24 holding.
  • Sio Capital Management first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • Sio Capital Management's Vir Biotechnology position peaked at $13.4M in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.